About
A biotech platform strategist and dealmaker, Holtzman founded DNX Corporation, served as Chief Business Officer at Millennium Pharmaceuticals, led Infinity Pharmaceuticals as CEO, was EVP of Corporate Development at Biogen, and was founding CEO of Decibel Therapeutics (acquired by Regeneron in 2023). He now advises biotech founders and holds executive chair and board roles at several biotech companies.
Experience
- Berklee College of MusicTrusteecurrent2014 — presentBoston, MA
- Decibel TherapeuticsPresident and Chief Executive Officer2016 — 2020Cambridge, MA
- Biogen IdecExecutive Vice President, Corporate Development2011 — 2016Cambridge, MA
- Infinity PharmaceuticalsFounder and Chair, Board of Directors2001 — 2012Cambridge, MA
- Infinity PharmaceuticalsPresident and CEO, Founder2001 — 2010Cambridge, MA
- Berklee College of MusicTrustee2003 — 2012Boston, MA
- The Hastings CenterVice Chairman, Board of Trustees1999 — 2010Garrison, NY
- Millennium PharmaceuticalsChief Business Officer1994 — 2001Cambridge, MA
- US National Bioethics CommissionPresidential Appointee1996 — 2001Washington, D.C.
- DNX CorporationFounder and Executive Vice President; President DNX Biotherapeutics1986 — 1994Princeton, NJ
Colleagues at Amplify Partners
Arjun Narayan
Venture Partner at Amplify Partners
Artur Bergman
Founder, Fastly at Amplify Partners
Barr Yaron
Partner at Amplify Partners
Barry McCardel
Founder, Hex at Amplify Partners
Bruno Fernandez-Ruiz
Venture Partner at Amplify Partners
Carlie Wright
Operations Associate at Amplify Partners
David Beyer
Partner at Amplify Partners
Elliot Hershberg
Scientist, Writer, and Investor on a mission to accelerate The Century of Biology
Frequently asked questions
- Who is Steve Holtzman?
- A biotech platform strategist and dealmaker, Holtzman founded DNX Corporation, served as Chief Business Officer at Millennium Pharmaceuticals, led Infinity Pharmaceuticals as CEO, was EVP of Corporate Development at Biogen, and was founding CEO of Decibel Therapeutics (acquired by Regeneron in 2023). He now advises biotech founders and holds executive chair and board roles at several biotech companies.
- Where does Steve Holtzman work?
- Steve Holtzman is Bio Advisor at Amplify Partners.
- Where did Steve Holtzman go to school?
- Steve Holtzman studied at University of Oxford (B.Phil., Philosophy); Michigan State University (BA, Philosophy).
Same school
Also attended University of Oxford1,229
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index Ventures
+ 1,223 more
Also attended Michigan State University141
Sumant MandalCo-Founder & Managing Partner at March Capital PartnersJay W. SchmelterCo-founder of RiverVest Venture Partners, funding and founding life science companiesKevin NovakFounder at Rackhouse Venture Management LpJim KirkwoodChief Science & Technology Development Officer/VP GTECH (Retired) at General Mills at Emerald Technology Ventures AgTamara SteffensManaging Director at Thomson Reuters VenturesKevin MorningstarGeneral Partner at Rockies Venture Adviser, Llc
+ 135 more
Shared employers
Also worked at Berklee College of Music4
Also worked at Decibel Therapeutics3
Also worked at Biogen Idec32
Jigar RaythathaInvestor at Third Rock VenturesRichard RansohoffVenture Partner at Third Rock VenturesIsaiah Baril-DoreInvestor at Index VenturesRoy LobbVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityJohn McCabePortfolio Company CFO & COO at Longwood Fund
+ 26 more
Also worked at Infinity Pharmaceuticals9
Paul MeloneInvestor at Third Rock VenturesJeffrey TongPartner at Third Rock VenturesJohn KeiltyVenture Partner at Third Rock VenturesVikas GoyalPartner at Longwood FundAndrew PalmerCo-Founder of Tamr at Underscore VCDavid GrayzelPartner at Atlas Venture
+ 3 more